Skip to content

EXTENSE PHARMA

In bankruptcy Private limited company (pre-2019)founded 2009KBO/BCE: BE 0821.673.538

Information for creditors

Enterprise Court of Liège, Namur division · Official Gazette of 21-12-2022
Appeal or third-party opposition 05-01-2023Filing the claim in RegSol 14-01-2023First verification report 25-01-2023Late claim 15-12-2023

Trustee: Karl Steinier. The judgment is more than a year old. A claim can no longer be filed, not even late. The trustee knows whether anything will still be paid out.

Lifetime

12 annual accounts with figures on one time axis
peak €102,801 (2017)
-€42,955▼ €62,607
lowest -€379,703 (2019)
-€120,752▼ €58,780
peak €278,549 (2017)
-€437,008▼ €120,752
€831,224▲ 7.6%
peak 1 FTE (2011)
-not published
Board1 name since 2009
1 director
Documentsfilings and deeds
24-10-202285 days late
2021micro format
Extension 19-10Extension 19-07Extension 22-03Gross margin from €19,652 to -€42,955Loss of €120,752Equity from -€316,256 to -€437,008

Key points

from the 2021 annual accounts, the last ones filed

Equity

-€437,008 from €278,549 in 2017

Equity fell below zero in 2019.

Losses

-€715,557 in four years
-153,1292018-379,7032019-61,9732020-120,7522021

Every financial year from 2018 to 2021 closed with a loss. 2019 was the heaviest.

Debts

€831,224 211% of the balance sheet
Financial debts 37%Suppliers 14%Other 49%

Of this, €715,600 falls due within a year.

Filings

12 annual accounts since 2010
AprilJune31 JulyOctober201020152020

Six of the last ten came late. The 2020 accounts came latest: 450 days after the end of the period.

Final months

51 days from reorganisation to bankruptcy
  • 25-10-2022 reorganisation opened
  • 15-12-2022 declared bankrupt
  • 21-12-2022 published in the Official Gazette
Turnover not published (micro format)

Board and ownership

Director, since 17-12-2009
  • 43 sharesdeed of 13-03-2017
Board & ownership

Recent changes

Address struck KBO administration
Bankruptcy published Enterprise Court of Liège, Namur division · judgment of 15-12-2022 · Bankruptcy
Registered office moved from Sambreville to Limal New registered office: Rue Charles Jaumotte 29-31 à 1300 LIMAL (Wavre) · Previous registered office: rue du Gay 87 à 5060 SAMBREVILLE · Board meeting of 23-11-2022 · Gazette deed
Extension of the stay refused Enterprise Court of Liège, Namur division · amicable agreement · judgment of 22-11-2022 · Judicial reorganisation
All 31 events

Official details

Source: KBO
Status
In bankruptcydeclared bankrupt on 15-12-2022
Legal form
Private limited company (pre-2019)
Activity
Agents specialised in the wholesale of other particular productsNACE 46180and 1 other
Establishment unit
2.183.994.5901380 Lasne, since 01-01-2010
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2021

€394,215▼ 13.6%
Filing
Filed on 24-10-2022
Financials

Insights on EXTENSE PHARMA

Equity fell from €278,549 in 2017 to -€437,008 in 2021, while debts rose from €720,092 to €831,224.

On 25 October 2022 the court opened a judicial reorganisation. 51 days later came the bankruptcy.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about EXTENSE PHARMA

What is the company number of EXTENSE PHARMA?
The company number of EXTENSE PHARMA is 0821.673.538. The VAT number is the same number with BE in front: BE 0821.673.538.
What does EXTENSE PHARMA do?
According to the KBO register, the main activity is agents specialised in the wholesale of other particular products (NACE 46180).
What is the legal form of EXTENSE PHARMA?
EXTENSE PHARMA is a private limited company (pre-2019) (BVBA).
When was EXTENSE PHARMA founded?
EXTENSE PHARMA was founded on 17-12-2009.
Is EXTENSE PHARMA still active?
A bankruptcy is running. A bankruptcy trustee manages the company.Company details
What is the turnover of EXTENSE PHARMA?
The annual accounts for financial year 2021 state no turnover. The micro format does not require it. In financial year 2018 turnover was €1.4m.Financials
Is EXTENSE PHARMA profitable?
In financial year 2021, EXTENSE PHARMA made a loss of €120,752.
Where can I find the annual accounts of EXTENSE PHARMA?
EXTENSE PHARMA filed 12 annual accounts with the National Bank of Belgium, the latest for financial year 2021.

Next steps

Keep this company with today's facts in a case file.